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Abstract
Sugar binding proteins and binders of intermediate sugar metabolites derived from microbes are
increasingly being used as reagents in new and expanding areas of biotechnology. The fixation of
carbon dioxide at emission source has recently emerged as a technology with potentially significant
implications for environmental biotechnology. Carbon dioxide is fixed onto a five carbon sugar D-
ribulose-1,5-bisphosphate. We present a review of enzymatic and non-enzymatic binding proteins,
for 3-phosphoglycerate (3PGA), 3-phosphoglyceraldehyde (3PGAL), dihydroxyacetone phosphate
(DHAP), xylulose-5-phosphate (X5P) and ribulose-1,5-bisphosphate  (RuBP) which could be
potentially used in reactors regenerating RuBP from 3PGA. A series of reactors combined in a
linear fashion has been previously shown to convert 3-PGA, (the product of fixed CO2 on RuBP as
starting material) into RuBP (Bhattacharya et al., 2004; Bhattacharya, 2001). This was the basis for
designing reactors harboring enzyme complexes/mixtures instead of linear combination of single-
enzyme reactors for conversion of 3PGA into RuBP. Specific sugars in such enzyme-complex
harboring reactors requires removal at key steps and fed to different reactors necessitating
reversible sugar binders. In this review we present an account of existing microbial sugar binding
proteins and their potential utility in these operations.
Review
Rapid industrialization has led to a dramatically acceler-
ated consumption of fossil fuels with a consequent
increase in atmospheric levels of the greenhouse gas car-
bon dioxide (CO2). This sustained increase of atmos-
pheric CO2 has already initiated a chain of events with
negative ecological consequences [1-3]. Failure to reduce
these greenhouse gas emissions will have a catastrophic
impact upon both the environment and the economy on
a global scale [4,5]. The reduction has to be brought about
by global concerted effort by all countries in order to be
effective and meaningful.
At one end of the spectrum – that of generation and utili-
zation of energy resulting in generation of carbon dioxide
– hydrocarbons serve as intermediaries for energy storage.
Hydrocarbons are not energy by themselves but store
energy in their bonds, which is released during
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combustion. They are thus intermediates for obtaining
stored bond energy within them and carbon dioxide is
emitted as a consequence of combustion to extract this
stored energy. In recent times hydrogen has received
renewed attention as the potential replacement for hydro-
carbons [6-10]. However, hydrogen too is an intermediary
for obtaining stored bond energy. Recent reports suggest
that hydrogen as intermediary may not be entirely free
from problems. Also, the problems from use of hydrogen
as fuel are yet to be fully realized or foreseen [11,12]. In
all these endeavors a key question, that whether the
hydrocarbons will be still retained as intermediaries in
energy utilization and the problem of air pollution caused
as a result of their combustion can be technologically
ameliorated, has not been looked in as much detail as per-
haps it should have been. This can possibly be achieved by
contained handling of carbon dioxide. The contained
handling and fixation of CO2 can be achieved biotechno-
logically, chemically or by a combination of both.
Sugar binding proteins derived from microbial and other
sources have been used for various applications such as
diagnostics and affinity purification [13,14], however
they have not been used in environmental biotechnolog-
ical applications. The possibility of their potential applica-
tion in environmental biotechnology and review of a few
potential candidates is presented here.
Scheme for generation of D-ribulose-1,5-bisphosphate (RuBP) from 3-phosphoglycerate (3PGA) obtained from fixation of CO2  on RuBP Figure 1
Scheme for generation of D-ribulose-1,5-bisphosphate (RuBP) from 3-phosphoglycerate (3PGA) obtained from fixation of CO2 
on RuBP. The continuous regeneration of RuBP in this scheme enables continuous fixation of CO2 at stationary emission sites.
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The methods in environmental biotechnology that ena-
bles efficient capture [15] and fixation of CO2 at emission
source/site into concatenated carbon compounds has
been pioneered by our group [16-19]. The first part in the
biocatalytic carbon dioxide fixation is the capture of gase-
ous CO2. We have pioneered novel reactors employing
immobilized carbonic anhydrase for this purpose [15].
Subsequent to capture the carbon dioxide becomes solu-
blized (as carbonic acid or bicarbonate). After adjustment
of pH using controllers and pH-stat the solution is fed to
immobilized Rubisco reactors [18] where acceptor D-Rib-
ulose-1,5-bisphosphate (RuBP) after CO2 fixation is con-
verted into 3-phosphoglycerate [16,17]. However,
inasmuch as the recycling of acceptor RuBP is central to
continuous CO2  fixation, we have invented a novel
scheme (Figure 1), which proceeds with no loss of CO2
(unlike cellular biochemical systems) in 11 steps in a
series of bioreactors [20]. This scheme is very different
from generation of RuBP from D-glucose for start-up
process [21] and employing 11 steps in different reactors
requiring large volume and weight. The linear combina-
tion of reactors with large volume and weight are unsuit-
An alternate arrangement of enzymes in the scheme outlined in Fig. 1 Figure 2
An alternate arrangement of enzymes in the scheme outlined in Fig. 1. This schemes harbors four reactors with indicated 
enzyme complexes enabling internal channeling, greatly reduces volume and weight for regenerating reactors with faster over-
all conversion rate to RuBP starting with 3PGA making the system compatible for application in mobile devices in addition to 
stationary emitters. The reactors may use the sugar binding entities at indicated positions, the hollow and solid symbols repre-
sent binding and release phase of the binding-molecules, the plus, circle, cylinder and box are symbols for 3PGA, DHAP, X5P 
and RuBP binders respectively.
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Table 1: Proteins that bind 3-phosphoglycerate
Source Mutation Remarks References
Enzymatic proteins
Phosphoglycerate mutase 1 (EC 5.4.2.1)
E. coli Glu327 Lower Vmax 26
S. cerevisiae Gly13Ser 2-fold increase in activity 27
S. cerevisiae His181Ala 11-fold increase in the Km 28
S. cerevisiae C-terminal 7 res. Deletion Loss of activity, retention of ligand binding 29
B. stearothermophilus S62A Loss of activity, retention of ligand binding 30
S. pombe H163Q Reduced mutase and phosphatase activities 31
E. coli R257A 11-fold increase in Vmax 26
E. coli R307A 700-fold decrease in Vmax 26
Enolase (EC 4.2.1.11)
S. cerrevisiae S39A Loss of over 90% activity 32
S. cerrevisiae H157A, H159A Loss of over 90% activity 33
S. cerrevisiae H159A Loss of over 98% activity 34
Escherichia coli N341D Loss of catalytic activity 35
S. cerrevisiae Gcr1-1 mutation 20-fold reduction in activity 36
Phosphoglycerate kinase, (EC 2.7.2.3)
S. cerrevisiae H388G Reduced kcat and Km 37
S. cerrevisiae R168K Increase in Km 38
S. cerrevisiae R168M Increase in Km 38
S. cerrevisiae H62D Increase in Km and Vmax 39
S. cerrevisiae D372N reduction in Vmax by 10-folds 40
S. cerrevisiae R38A Complete loss of activity 41
S. cerrevisiae R38Q Complete loss of activity 41
S. cerrevisiae R65Q Increase in Kd, decrease in Km 42
S. cerrevisiae R65A Increase in Kd, decrease in Km 42
S. cerrevisiae R65S Increase in Kd, decrease in Km 42
S. cerrevisiae F194W (and F194L) decrease in Km, Vmax 43
S. cerrevisiae R203P Reduction in kcat 44
Bisphosphoglycerate mutase (EC 5.4.2.4)
S. cerevisiae H181A Decrease in kcat 28
Transketolase
S. cerevisiae E418Q, E418A 98–99% reduction in activity 45
S. cerevisiae E418A E418 is essential for catalytic activity 45
S. cerevisiae H103A, H103N and H103F 95–99.9% reduced activity 46
S. cerevisiae E162A (G) Impaired catalytic activity and binding 47
S. cerevisiae D382N(A) Impaired catalytic activity and binding 47
S. cerevisiae H481A/S/G 98.5% reduced specific activity 48
S. cerevisiae N477A 1000-fold decrease in kcat/Km 49
S. cerevisiae H263A Reduced activity 50
D-3-phosphoglycerate dehydrogenase 2 (EC 1.1.1.95)
Escherichia coli L-Serine Reduced activity 51
Triosephosphate isomerase
Kluyveromyces lactis Kltpi1 mutant Loss of activity 52
Plasmodium falciparum Y74G Reduced stability 53
Plasmodium falciparum C13D 7-fold reduction in activity 54
Trypanosoma brucei W12F Reduced stability 55
Leishmania mexicana E65Q Increased stability 56
K. lactis DeltaTPI1 mutants Complete loss of activity 57
Vibrio marinus A238S mutant Reduced activity 58
Trypanosoma brucei C14L Reduced stability and altered kinetics 59
Saccharomyces cerevisiae K12R Vmax reduced by factor of 180 60
Saccharomyces cerevisiae K12H No catalytic activity at neutral pH 60
Saccharomyces cerevisiae E165D 100-fold loss in catalytic activity 61
Salmonella typhimurium R179L Reduction in binding affinity 62
Trypanosoma brucei H47N Reduced stability 63
Escherechia coli E165D 100-fold reduction in specific activity 64
Escherechia coli N78D Lower kcat 65
Saccharomyces cerevisiae H95G 400-fold decrease in catalytic activity 66Microbial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/7
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able for use with mobile CO2 emitters leaving only the
stationary source of emission to be controlled using this
technology [17]. To circumvent these problems we have
devised a new scheme presented in Figure 2[22]. Based on
this scheme, we have designed enzymes as functionally
interacting complexes/interactomes or successive conver-
sion in radial flow with layers of uniformly oriented
enzymes in concentric circle with axial collection flow sys-
tem for three enzymes in first reactor for the scheme pre-
sented in Figure 2. The four reactors harboring enzymatic
complexes/mixtures replace the current 11 reactors. This
leads to a faster conversion rate and requires less volume
and material weight. However, 4 sugar moieties [3-phos-
phoglyceraldehyde (3PGAL), Dihydroxyacetone phos-
phate (DHAP), Xylulose-5-phosphate (X5P) and
Ribulose-1, 5-bisphosphate (RuBP)] must be separated at
four key steps, as illustrated in Figure 2. In figure 2, using
four symbols with solid for bound state and empty for
released state, for potential binders: plus for 3PGA, circle
for DHAP, cylinder for X5P and box for RuBP, the possible
place for utility of these binders have been depicted. In the
course of this review, we will consider the availability of
enzymatic proteins and non-enzymatic proteins that
would be potentially useful as specific binders for these
sugar molecules. With a recombinant mutant enzyme we
illustrate that such an approach has potential to be used
as an in-situ reversible binding matrix for sugar binding
and release.
Potential utilizable sugar binding proteins in RuBP 
regeneration
Three categories of binding proteins can be potentially
employed for differential absorption of sugars and for
subsequent elution and feeding the reactors downstream
in conversion cascade. These are: mutant enzymatic pro-
teins that retain the ability of binding but completely lack
any catalytic activity, lectins or proteins of non-immuno-
genic origin [23] having more than one binding site for
the sugar (in nature they cause agglutination of due to
sugar binding at multiple sites) and mutant or wild type
receptors that binds sugars but are incapable of eliciting
further biological activities. The desirable proteins in all
these categories are those for which binding affinity is
high in a condition close to pH of the emanating solution
from the reactor and other conditions for reactor effluent,
ability to bind reversibly with respect to some simple but
easily manipulable physicochemical parameter (such as
temperature, pH, salt concentration), and the ability to be
easily attached to a matrix using simple chemistry without
loss of binding ability and a long shelf life.
Non-enzymatic proteins
Phosphoglycerate transporter protein
Salmonella typhimurium 67
Salmonella typhimurium 68
Bacillus cereus 69
Bacillus anthracis 70
Salmonella typhi 71
Salmonella typhi 72
Histone like DNA-binding protein (HU homolog)
Mycobacterium leprae 73
Mycobacterium leprae 74
Mycobacterium tuberculosis 75
Mycobacterium tuberculosis 76
40S ribosomal protein SA (P40)
Chlorohydra viridissima 77
Strongylocentrotus purpuratus 78
Tripneustes gratilla 79
Urechis caupo 79
Laminin-binding protein
Streptococcus agalactiae 80
Streptococcus agalactiae 81
Streptococcus pyogenes 82
Streptococcus agalactiae 83
Streptococcus agalactiae 83
Streptococcus agalactiae 83
Serine-rich protein (TYE7)
Saccharomyces cerevisiae 84
Saccharomyces cerevisiae 85
Table 1: Proteins that bind 3-phosphoglycerate (Continued)Microbial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/7
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We undertook this review because, although the compre-
hensive information on a large number of enzymes have
been accumulated in BRENDA database [24,25], but the
systematic information on their mutants is lacking and
non-enzymatic binders of sugar ligands are not identified
/ listed in the database.
Table 2: Proteins that bind Dihydroxyacetone phosphate
Source Organism Mutation Remarks References
Enzymatic proteins
Glyceraldehyde-3-phosphate dehydrogenase
S. cerevisiae ald5 mutant Higher catalytic activity 86
S. cerevisiae gpd2 delta mutant Improved ethanol production 87
Dihydroxyacetone kinase 1 (Glycerone kinase 1)
Hansenula polymorpha per6-210 mutant Lacks enzymatic activity 88
Glycerol-3-phosphate acyltransferase
Escherichia coli G1045A Reduced specific activity, increased Km 89
Escherichia coli D311E Reduced catalytic activity 90
S. cerevisiae tpa1 mutant 2-fold decrease in activity 91
NAD(P)H-dependent dihydroxyacetone-phosphate reductase
Escherichia coli Q15R/K, W37R/K Inactive with NADP+ 92
Escherichia coli Q15K-W37R and Q15R-W37R 30-fold higher Km for NADP+ 92
Escherichia coli gamma-R97Q 10-fold increased Km for NAD 93
Escherichia coli G252A Reverse transhydrogenation activity 94
Pseudomonas fluorescens K295A and K295M 104–106-fold lower turnover 95
M. thermoautotrophicum R11K and R136K Decreased Km 96
Alkyl-dihydroxyacetonephosphate synthase
Hansenula polymorpha ts6 and ts44 mutant Peroxisomes absent 97
Dihydroxyacetone phosphate acyltransferase
Corynebacterium glutamicum S187C Reduced enzymatic activity 98
Triose phosphate isomerase
Kluyveromyces lactis Kltpi1 mutant Loss of enzymatic activity 52
Plasmodium falciparum Y74G Reduced stability 53, 54
Plasmodium falciparum C13D 7-fold reduction in the enzymatic activity 53, 54
Trypanosoma brucei W12F Reduced stability 55
Leishmania mexicana E65Q Increased stability 56
K. lactis DeltaTPI1 mutants Complete loss of activity 57
Bacillus stearothermophilus N12H Prevent deamidation at high temperature 99
Vibrio marinus A238S catalytic activity reduced 58
Trypanosoma brucei C14L Reduced stability and altered kinetics 59
Saccharomyces cerevisiae K12R Vmax reduced by a factor of 180, Km elevated 60
Saccharomyces cerevisiae K12H No catalytic activity at neutral pH 60
Saccharomyces cerevisiae E165D 1000-fold reduction in catalytic activity 61
Salmonella typhimurium R179L Reduction in binding affinity 62
Trypanosoma brucei H47N Reduced stability 63
Escherechia coli E165D 1000-fold reduction in specific activity 64
Escherechia coli N78D Lowered Kcat 65
Saccharomyces cerevisiae H95G 400-fold decrease in catalytic activity 66
Non-enzymatic protein
DHAP transporter
Saccharomyces cerevisiae 100
mycoplasma mycoides 101
E. coli 102
Pseudomonas aeruginosa 103
Escherichia coli 104
Escherichia coli 105
Escherichia coli 106
Escherichia coli 107Microbial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/7
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Proteins that bind 3-phosphoglycerate/3-
phosphoglyceraldehye
Both enzymatic and non-enzymatic proteins bind these
sugar entities. A number of mutants of many enzymes that
bind to either 3-phosphoglycerate or 3-phosphoglyceral-
dehyde are also known, for example, Phosphoglycero-
mutase (EC 5.4.2.1), Enolase (EC 4.2.1.11), Mannosyl-3-
phosphoglycerate phosphatase (EC 3.1.3.70), Mannosyl-
3-phosphoglycerate synthase (EC 2.4.1.217), Phos-
phoglycerate kinase, (EC 2.7.2.3), Bisphosphoglycerate
mutase (EC 5.4.2.4), 2,3-bisphosphoglycerate-independ-
ent phosphoglycerate mutase (EC 5.4.2.1), D-3-phos-
phoglycerate dehydrogenase 2 (EC 1.1.1.95), Cyclic 2,3-
diphosphoglycerate-synthetase, Phosphoglycerate dehy-
drogenase, Transketolase, and Triosephosphate isomer-
ase, BRENDA database shows only three enzymes:
Phosphoglycerate dehydrogenase, Mannosyl-3-phos-
phoglycerate synthase and Phosphoglycerate kinase. A
number of mutants of enzymes that binds 3-phos-
phoglycerate and shows some change in enzymatic activ-
ity or kinetic parameters are listed in Table 1. Many of
these proteins are reported to retain ligand binding ability
with varying degree of loss in catalytic ability (inactive
mutants are in bold face), the non-enzymatic protein that
also has been reported in literature has been placed
towards the bottom part of Table 1. The proteins which
retain binding ability but with complete loss in catalytic
activity are the ones which warrant further investigation in
batch and continuous processes for exploring their suita-
bility as binding proteins in continuous RuBP
regenerating reactors (Figure 2). A number of non-enzy-
matic protein summarized in Table 1 also warrant further
exploration. The only binding entity of significance for 3-
phosphoglyceraldehyde is 3-phosphoglyceraldehyde
dehydrogenase (EC 1.2.1.12) and has not been reviewed.
Proteins that bind dihydroxyacetone phosphate
Several enzymes: dihydroxyacetone phosphate acyltrans-
ferase, Glycerol-3-phosphate dehydrogenase, Aldolase A,
fructose-bisphosphatase, Aldolase B, fructose-bisphos-
phatase, L-aspartate oxidase, Quinolinate synthetase A,
Dihydroxyacetone kinase 1 (Glycerone kinase 1), Glyc-
erol-3-phosphate acyltransferase, NAD(P)H-dependent
dihydroxyacetone-phosphate reductase, Dihydroxyace-
tone phosphate acyltransferase, Alkyl-dihydroxyace-
tonephosphate synthase, Dihydroxyacetone kinase
isoenzyme I, Alpha-glycerophosphate oxidase and Triose
phosphate isomerase binds DHAP (Table 2), however,
BRENDA shows only four of these proteins, glycerol-3-
phosphate dehydrogenase (EC 1.1.1.8), acylglycerone-
phosphate reductase (EC 1.1.1.101), glycerone-phos-
phate O-acyltransferase (EC 2.3.1.42) and alkylglycerone-
phosphate synthase (2.5.1.26). The mutants of enzymes
with no chemical conversion ability but with high affinity
for binding dihydroxyacetone phosphate but very low
affinity for other proteins and reversible binding with
respect to temperature, salt or pH are desirable properties
for the binders.
Proteins binding xylulose-5-phosphate
As shown in Table 3 several enzymatic proteins binds to
xylulose-5-phosphate. Xylulose-5-phosphate phosphoke-
tolase, Dihydroxyacetone synthase, xylulose kinase,
Protein phosphatase 2A B alpha isoform, Xylulose 5-
phosphate-activated protein phosphatase, 1-deoxy-D-
xylulose 5-phosphate reductoisomerase, 1-deoxy-D-xylu-
lose 5-phosphate synthase 1 and 2 are examples of such
Table 3: Proteins that bind Xylulose-5-phosphate
Source Mutation Remarks References
Enzymatic proteins
1-deoxy-D-xylulose 5-phosphate reductoisomerase
Escherichia coli E231K 0.24% wild-type kcat 108
Escherichia coli H153Q 3.5-fold increase in Km 108
Escherichia coli H209Q 7.6-fold increase in Km 108
Escherichia coli H257Q 19-fold increase in Km 108
xylulose kinase
Escherichia coli XylB- mutant Lack of growth on xylitol 109
Dihydroxyacetone synthase
Hansenula polymorpha Pex1–6(ts) Peroxisome-deficient 110
Hansenula polymorpha Deltapex14 Lack normal peroxisomes 111
Non-enzymatic proteins
Xylulose-5-phosphate receptor
Mycobacterium tuberculosis 112
Xylulose-5-phosphate trasporter
Arabidopsis sp. 113Microbial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/7
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enzymes. The non-enzymatic xylulose-5-phosphate bind-
ers are shown in the bottom part of Table 3. BRENDA
database shows following five proteins, 1-deoxy-D-xylu-
lose-5-phosphate reductoisomerase (EC 1.1.1.267), for-
maldehyde transketolase (EC 2.2.1.3), 1-deoxy-D-
xylulose 5-phosphate synthase (EC 2.2.1.7), Phosphoke-
tolase (EC 4.1.2.9), Ribulose-phosphate 3-epimerase (EC
5.1.3.1).
Proteins binding D-Ribulose-1,5-bisphosphate
A number of Ribulose-1,5-bisphosphate and metaboliz-
ing enzymes such as Ribulose phosphate kinase and their
mutants binds D-ribulose-1,5-bisphosphate. The RuBP
binding entities devoid of any enzymatic activities are very
valuable in reactors necessitating extraction and
separation of RuBP from other sugar compounds (Table
4). Very few non-enzymatic proteins bind RuBP and none
of them are microbial sources, and hence have not been
The recombinant his-tagged wild-type and R38Q mutant 3-phosphoglycerate kinase was subjected to affinity purification on Ni- NTA column as described previously [20] Figure 3
The recombinant his-tagged wild-type and R38Q mutant 3-phosphoglycerate kinase was subjected to affinity purification on Ni-
NTA column as described previously [20]. A. SDS-PAGE of recombinant wild-type and R38Q mutant S. cerevisiae 3-phos-
phoglycerate kinase. The proteins (1 and 1.8 µg respectively) was separated in 10% polyacrylamide gel and stained with Coom-
massie blue R250. B. TLC analysis of sugars prior to and after in-situ separation with R38Q. The recombinant R38Q mutant 
(R38Q-PGK) was coupled with Protein A sepharose beads and incubated overnight with a mixture of sugars, 3-phosphoglycer-
ate (3PGA), ribulose-5-phosphate (R5P), Glucose-6-phosphate (G6P) and Fructose-6-posphate (F1,6-bP). After washing with 
180 mM NaCl, the sugars were eluted with 1 M NaCl. Lane 1, mixture of sugar prior to incubation with R38Q-PGK and Lane-
2 after elution with 1 M NaCl.
A
PGK R38Q-PGK
3PGA
R5P
G6P
F1,6-bP
12
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Table 4: Enzymes that bind D-Ribulose-1,5-bisphosphate
Source organism Mutation Remarks References
Rubisco
Chamydomonas reinhardtii C256F, K258R, L265V 85% decrease in Catalytic efficiency (Vmax/Km) 114
Chamydomonas reinhardtii G54V 83% decrease in the carboxylation-Vmax 115
Anacystis nidulans L339F, A340L, S341M Decrease in Kcat and (Vmax/Km) by 90%and 36.3% respectively 116
Anacystis nidulans T342I, K343L Decrease in Kcat and (Vmax/Km) by 90%and 36.3% respectively 116
Anacystis nidulans T342I Decrease in Kcat and (Vmax/Km) 40.5%and 40.5% respectively 116
Anacystis nidulans K343L Decrease in Kcat and (Vmax/Km) 48.1%and 18.5% respectively 116
Anacystis nidulans V346Y, D347H, L348T Inactive 116
Anacystis nidulans L326I Decrease in Kcat and (Vmax/Km) 54.4%and 34.2% respectively 116
Anacystis nidulans S328A Decrease in Kcat and (Vmax/Km) 5.6%and 41.5% respectively 116
Anacystis nidulans N123H 16.5% decrease in Kcat 116
Anacystis nidulans L332M, L332I >65% decrease in carboxylase but not in oxygenase activity 117
Anacystis nidulans >65% decrease in carboxylase but not in oxygenase activity 117
Anacystis nidulans L332V 67% decrease in specificity factor (CO2/O2)1 1 7
Anacystis nidulans L332T 67% decrease in specificity factor (CO2/O2)1 1 7
Anacystis nidulans L332A >65% decrease in specificity and carboxylase activity 117
Rhodospirillum rubrum deleation of F327 99.5% decrease in carboxylase activity 118
Rhodospirillum rubrum F327L Increase in Km (RuBP) 118
Rhodospirillum rubrum F327V Increase in Km (RuBP) 118
Rhodospirillum rubrum F327A Increase in Km (RuBP) 118
Rhodospirillum rubrum F327G 165-fold increase in Km (RuBP) 118
Rhodospirillum rubrum N111G Km(RuBP), kcat are 320 fold increased and 88-fold decreased 119
Rhodospirillum rubrum N111L Mutant show a very low carboxylase activity 119
Rhodospirillum rubrum N111Q Mutant show a very low carboxylase activity 119
Rhodospirillum rubrum N111B Mutant show a very low carboxylase activity 119
Synechococcus sp.PCC6301 I87V Mutant show a very low carboxylase activity (kcat = 35%) 120
Synechococcus sp.PCC6301 R88K Mutant show a very low carboxylase activity (kcat = 35%) 120
Synechococcus sp.PCC6301 G91V Mutant show a very low carboxylase activity (kcat = 35%) 120
Synechococcus sp.PCC6301 F92L Mutant show a very low carboxylase activity (kcat = 35%) 120
Synechococcus sp.PCC6803 C172A 40–60% decline in Rubisco turnover number 121
Chlamydomonas reinhardtii N123G Decrease in specificity factor 122
Chlamydomonas reinhardtii S379A Decrease in specificity factor 122
Anacystis nidulans S376 C 99% and ~99.9% decrease in carboxylase and oxygenase 
activity
123
Anacystis nidulans S376T 99% and ~99.9% decrease in carboxylase and oxygenase 
activity
123
Anacystis nidulans S376 A 99% and ~16% decrease in carboxylase and oxygenase activity 123
Rhodospirillum rubrum I164T 6% decrease in carboxylase activity with 40-fold lower Kcat/
Km
124
Rhodospirillum rubrum I164N 1% decrease in carboxylase activity with 900-fold lower Kcat/
Km
124
Rhodospirillum rubrum I164B 0.01–1% decrease in carboxylase activity 124
Rhodospirillum rubrum H287N 103-fold decrase in carboxylation catalysis 125
Rhodospirillum rubrum H287Q 105-fold decrase in carboxylation catalysis 125
Rhodospirillum rubrum M330L 126
Rubisco (large subunit)
Chamydomonas reinhardtii R59A Decrease in Vmax for carboxylation reaction 127
Chamydomonas reinhardtii Y67A Decrease in Vmax for carboxylation reaction 127
Chamydomonas reinhardtii Y68A Decrease in Vmax for carboxylation reaction 127
Chamydomonas reinhardtii D69A Decrease in Vmax for carboxylation reaction 127
Chamydomonas reinhardtii R71A decrease in Vmax (for carboxylation reaction) and thermal 
stability
127
Chamydomonas reinhardtii A222T, V262L, L290F Improved specificity factor and thermal stability 128
Phosphoribulokinase
Rhodobacter sphaeroides T18A 8-fold decrease in Vmax 129
Rhodobacter sphaeroides S14A 40-fold decrease in Vmax 129
Rhodobacter sphaeroides S19A 500-fold and >1500-fold decrease in Vmax and Vmax/Km of RuBP 129
Rhodobacter sphaeroides K165M, K165C 103-fold decrease in catalytic activity 130
Rhodobacter sphaeroides R168Q >300-fold decrease in catalytic efficiency 131
Rhodobacter sphaeroides R173Q 15-fold decrease in Vmax, 100-fold increase in Km for RuBP 131Microbial Cell Factories 2004, 3 http://www.microbialcellfactories.com/content/3/1/7
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incorporated in this review, Rubisco associated protein
from soybean is one of them, that show significant RuBP
binding [137].
Illustrating example
In order to illustrate the utility of non-catalytic enzymatic
mutants as specific sugar binders for in-situ separation in
reactors, recombinant Saccharomyces cerevisiae 3-phos-
phoglycerate kinase mutant R38Q [41] was prepared.
Mutagenesis was carried out using wild type protein con-
struct in plasmid pET19b as a template. The R38Q mutant
was constructed with the Quickchange/Chameleon site-
directed mutagenesis kit from stategene using primers as
described elsewhere [41]. DNA sequencing of the plasmid
identified the mutant. Recombinant wild-type and
mutant (R38Q) 3-phosphoglycerate kinase (PGK) were
purified to apparent homogeneity as described previously
[20] have been shown in Figure 3A. The wild-type and
mutant protein was incubated with 10 mM 3-phos-
phoglycerate barium salt (3PGA) in 50 mM Tris-Cl buffer,
pH 7.5 containing 50 mM NaCl for overnight at room
temperature. No modification of 3PGA was observed after
incubation with R38Q mutant protein (data not shown).
The R38Q was coupled with Protein A sepharose beads
using dimethylpimelimidate. The recombinant R38Q
mutant protein beads (R38Q-PGK) was incubated over-
night at room temperature with a mixture of sugars, 3-
phosphoglycerate, barium salt (3PGA), ribulose-5-phos-
phate (R5P), Glucose-6-phosphate (G6P) and Fructose-6-
posphate (F1,6-bP) each at a concentration of 10 mM in a
volume of 200 µl. After incubation they were washed with
1.5 ml of 180 mM NaCl in 50 mM Tris-Cl buffer, pH 7.5.
They were subjected to elution with 1 M NaCl. Lane 1,
mixture of sugar prior to incubation with R38Q-PGK and
Lane-2 after elution with 1 M NaCl.
Conclusion
The enzyme-mutants lacking catalytic activity represent an
important group of proteins that could be used for devel-
opment of sugar-binding proteins reversible with respect
to physicochemical parameters such as pH or salt concen-
tration. Nevertheless, the non-enzymatic proteins also
represent a suitable repertoire of such potential scaffolds,
which could be used for development as sugar-binding
proteins to be used in reactors for simultaneous
separation of sugars that would be used in subsequent
conversion steps. We have developed a RuBP production
scheme from 3PGA [16,17] and also a de novo RuBP pro-
duction scheme from D-glucose [21] for continuous CO2
fixation and for start-up of the fixation respectively
employing series of reactors. Both systems for production
of RuBP will benefit from specific sugar binders but
besides their use in environmental biotechnology, they
will find application in diagnostics, separation technolo-
gies and also as research reagents.
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